<img alt="" src="https://secure.hiss3lark.com/174537.png" style="display:none;">
LSX-Blog.png

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Q&A: Fostering a start-up and growth ecosystem in ...

Jose Lozano, President and Chief Executive Officer at Choose New Jersey, ou...

Read More

The Future of Digital Health: Q&A with Capricorn V...

As new technologies look to play an ever-increasing role in addressing heal...

Read More

Investing in Early-Stage Innovation: Q&A with Sano...

How are established investors working to foster innovation in today’s biote...

Read More

Medtech Investment: Q&A with Panakès Partners’ Ale...

On 5 February 2019, a panel of leading medtech investors will open the 5th ...

Read More

Series A Spotlight: Q&A with Protembis’ Conrad Ras...

In October 2018, German medical device company Protembis closed an oversubs...

Read More

LSX World Congress 2019 fast approaches

On 5-6 February 2019, international life sciences investors, C-level execut...

Read More

Q&A: Life sciences innovation in New Jersey

Jose Lozano, President and Chief Executive Officer at Choose New Jersey, di...

Read More

Life science leaders to address strategic company ...

Senior executives and investors in the life sciences sector will convene in...

Read More

Lifestars Awards 2018 celebrate life science succe...

LSX (formerly Biotech and Money) hosted the Lifestars Awards at the Honoura...

Read More

Addressing emerging themes in life science IP

Marks & Clerk’s intellectual property (IP) summit in Cambridge on 16 Octobe...

Read More

Driving developments to defeat ageing: Q&A with Au...

In February 2019, key stakeholders in the growing longevity industry will c...

Read More

Rethinking the growth capital challenge in UK life...

Investors, entrepreneurs and deal makers in the UK life sciences industry m...

Read More

Add Your Response